Mantena; Narender Dev

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mantena; Narender Dev.The latest application filed is for "multivalent pneumococcal polysaccharide-protein conjugate vaccine".

Company Profile

11.7.14

Mantena; Narender Dev - Hyderabad IN
Mantena; Narender Dev - Telangana IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Semi-synthetic meningococcal conjugate vaccine Grant 11,420,993 - Goel , et al. August 23, 2	2022-08-23
Multivalent Pneumococcal Polysaccharide-protein Conjugate Vaccine App 20220143166 - BURKI; Rajendar ; et al.	2022-05-12
Process for the preparation of low molecular weight heparin Grant 11,299,558 - Vedula , et al. April 12, 2	2022-04-12
Purified Capsular Polysaccharides Of Streptococcus Pneumoniae App 20210346488 - Burki; Rajendar ; et al.	2021-11-11
Vaccine Formulations Comprising Preservative App 20210322533 - Sangareddy; Veerapandu ; et al.	2021-10-21
Multivalent pneumococcal conjugate vaccine Grant 11,147,863 - Matur , et al. October 19, 2	2021-10-19
Method for high level production of CRM.sub.197 Grant 11,098,089 - Masilamani , et al. August 24, 2	2021-08-24
Process For The Preparation Of Low Molecular Weight Heparin App 20210189019 - Vedula; Manohar Sarma ; et al.	2021-06-24
Industrially scalable process for recovering biologically active recombinant carrier proteins Grant 10,927,149 - Goel , et al. February 23, 2	2021-02-23
Improved Process For The Preparation Of Dalteparin Sodium App 20210040239 - Chintakunta; Vamsee Krishna ; et al.	2021-02-11
Method For Separation Of Protein And Other Impurities From Microbial Capsular Polysaccharides App 20210017300 - Matur; Ramesh Venkat ; et al.	2021-01-21
Expression Of Pneumococcal Surface Protein A (pspa) App 20210009641 - Sriraman; Rajan ; et al.	2021-01-14
Method for separation of protein and other impurities from microbial capsular polysaccharides Grant 10,836,839 - Matur , et al. November 17, 2	2020-11-17
An Improved Method For High Level Production Of Crm197 App 20200277341 - Masilamani; Balamurali ; et al.	2020-09-03
Novel Semi-synthetic Meningococcal Conjugate Vaccine App 20190389894 - Goel; Akshay ; et al.	2019-12-26
Multivalent Pneumococcal Conjugate Vaccine App 20190240308 - Matur; Ramesh Venkat ; et al.	2019-08-08
Multivalent Pneumococcal Vaccine Compositions Comprising Polysaccharide-protein Conjugates App 20190224295 - Matur; Ramesh Venkat ; et al.	2019-07-25
Codon optimized polynucleotide for high level expression of CRM197 Grant 10,280,409 - Goel , et al.	2019-05-07
Industrially Scalable Process For Recovering Biologically Active Recombinant Carrier Proteins App 20180327457 - Goel; Akshay ; et al.	2018-11-15
Method For Separation Of Protein And Other Impurities From Microbial Capsular Polysaccharides App 20180155453 - Matur; Ramesh Venkat ; et al.	2018-06-07
Codon Optimized Polynucleotide For High Level Expression Of Crm197 App 20170306302 - Goel; Akshay ; et al.	2017-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.